PROCESSA PHARMACEUTICALS INC
Q2 2026 13F Holders
Symbol
PCSA
CUSIP
74275C403
Type
Equity
Class
COM SHS
Num filings
12
Total reported value, excl. options
$498 k
Compare 2026 Q2 to
2026 Q1
2025 Q4
Manager
Report Date
Value ($000)
Shares
Option Type